MktsMarkets

Cadrenal Therapeutics, Inc.
NASDAQ: CVKDKey statistics
CVKD News
Stories mentioning CVKD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 772.00 | 667.00 | 688.00 | 1,077 | 1,668 | 1,537 | 785.00 | 1,254 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 2,514 | 3,065 | 2,734 | 3,734 | 3,928 | 4,278 | 2,460 | 2,467 |
| Operating Income (Loss) | (2,514) | (3,065) | (2,734) | (3,734) | (3,928) | (4,278) | (2,460) | (2,467) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (2,497) | (3,039) | (2,686) | (3,667) | (3,845) | (4,187) | (2,408) | (2,393) |
| Earnings Per Share (Basic) | (1.04) | (1.52) | (1.31) | (1.87) | (2.09) | (3.43) | (2.18) | (2.24) |
| Earnings Per Share (Diluted) | (1.04) | (1.52) | (1.31) | (1.87) | (2.09) | (3.43) | (2.18) | (2.24) |
| Weighted Average Shares Outstanding (Basic) | 2,408 | 1,994 | 2,044 | 1,962 | 1,844 | 1,220 | 1,104 | 1,067 |
| Weighted Average Shares Outstanding (Diluted) | 2,408 | 1,994 | 2,044 | 1,962 | 1,844 | 1,220 | 1,104 | 1,067 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CVKD
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) is a stock listed on the Nasdaq Stock Market under the ticker symbol CVKD. It last traded at $1.75 (Nov 18, 2026, 12:01 PM ET), down 6.9% on the day. That gives Cadrenal Therapeutics a market capitalisation of $6.7M.
Over the past 52 weeks CVKD has traded between $0.8200 and $12.50.
For the quarter ended Mar 31, 2026 it reported a net loss of $2.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$2.5M |
| Dec 31, 2025 | — | -$3.0M |
| Sep 30, 2025 | — | -$2.7M |
| Jun 30, 2025 | — | -$3.7M |
From Cadrenal Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…